Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC
Trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretreated mCRC
Preview: World Cancer Congress 2024
Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Antibody drug conjugates in lung cancer
Research highlights in gastrointestinal tumours
Research highlights in lung cancer
Treatment of anxiety and depression in cancer patients using intergtaive medicine
Updates from ASCO 2024 in gastrointestinal tumours
Research highlights in breast cancer
GIST tumours and soft tissue sarcomas
Hormonal receptor positive breast cancer adjuvant and metastatic indications